Perdagangan Bonus BioGroup Ltd. - BBIXF CFD
Tambah ke favorit- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
Spread | - | ||||||||
Biaya inap posisi Long
Long position overnight fee
Kunjungi platform | -0.024874% | ||||||||
Biaya inap posisi short
Short position overnight fee
Kunjungi platform | 0.002651% | ||||||||
Waktu biaya inap | 21:00 (UTC) | ||||||||
Kuantitas min. yang diperdagangkan | 1 | ||||||||
Mata uang | USD | ||||||||
Margin | 20% | ||||||||
Bursa efek | United States of America | ||||||||
Komisi perdagangan | 0% |
*Information provided by Capital.com
Key Stats
Prev. Close* | N/A |
Open* | N/A |
1-Year Change* | N/A |
Day's Range* | N/A |
52 wk Range | 0.21-1.44 |
Average Volume (10 days) | 2.51M |
Average Volume (3 months) | 105.72M |
Market Cap | 249.94M |
P/E Ratio | -100.00K |
Shares Outstanding | 1.17B |
Revenue | N/A |
EPS | -0.03 |
Dividend (Yield %) | N/A |
Beta | 2.10 |
Next Earnings Date | N/A |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|
Bonus BioGroup Ltd. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 |
Revenue | 0 | 0 | |||
Total Operating Expense | 64.735 | 19.444 | 20.909 | 18.45 | 20.13 |
Selling/General/Admin. Expenses, Total | 43.75 | 8.023 | 9.752 | 7.567 | 9.201 |
Research & Development | 19.509 | 10.354 | 10.08 | 10.686 | 10.767 |
Other Operating Expenses, Total | |||||
Operating Income | -64.735 | -19.444 | -20.909 | -18.45 | -20.13 |
Other, Net | -24.936 | -1.408 | -0.195 | -0.364 | -0.067 |
Net Income Before Taxes | -90.076 | -22.021 | -22.24 | -18.735 | -20.197 |
Net Income After Taxes | -90.076 | -22.021 | -22.24 | -18.735 | -20.197 |
Net Income Before Extra. Items | -90.076 | -22.021 | -22.24 | -18.735 | -20.197 |
Net Income | -90.076 | -22.021 | -22.24 | -18.735 | -20.197 |
Income Available to Common Excl. Extra. Items | -90.076 | -22.021 | -22.24 | -18.735 | -20.197 |
Income Available to Common Incl. Extra. Items | -90.076 | -22.021 | -22.24 | -18.735 | -20.197 |
Diluted Net Income | -90.076 | -22.021 | -22.24 | -18.735 | -20.197 |
Diluted Weighted Average Shares | 1154.06 | 998.981 | 841.467 | 811.497 | 808.995 |
Diluted EPS Excluding Extraordinary Items | -0.07805 | -0.02204 | -0.02643 | -0.02309 | -0.02497 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.07805 | -0.02204 | -0.02643 | -0.02309 | -0.02497 |
Depreciation / Amortization | 1.476 | 1.067 | 1.077 | 0.197 | 0.162 |
Interest Income (Expense), Net Non-Operating | -0.405 | -1.169 | -1.136 | 0.079 |
Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 |
Total Operating Expense | 8.269 | 9.259 | 9.579 | 9.571 | 10.375 |
Selling/General/Admin. Expenses, Total | 3.679 | 3.745 | 3.645 | 4.117 | 3.635 |
Research & Development | 4.59 | 5.514 | 5.934 | 5.454 | 6.74 |
Operating Income | -8.269 | -9.259 | -9.579 | -9.571 | -10.375 |
Interest Income (Expense), Net Non-Operating | 0.345 | 4.647 | 2.506 | -0.463 | -0.005 |
Other, Net | -8.176 | -0.681 | -0.231 | -5.973 | -1.148 |
Net Income Before Taxes | -16.1 | -5.293 | -7.304 | -16.007 | -11.528 |
Net Income After Taxes | -16.1 | -5.293 | -7.304 | -16.007 | -11.528 |
Net Income Before Extra. Items | -16.1 | -5.293 | -7.304 | -16.007 | -11.528 |
Net Income | -16.1 | -5.293 | -7.304 | -16.007 | -11.528 |
Income Available to Common Excl. Extra. Items | -16.1 | -5.293 | -7.304 | -16.007 | -11.528 |
Income Available to Common Incl. Extra. Items | -16.1 | -5.293 | -7.304 | -16.007 | -11.528 |
Diluted Net Income | -16.1 | -5.293 | -7.304 | -16.007 | -11.528 |
Diluted Weighted Average Shares | 1167.93 | 1167.93 | 1167.93 | 1155.96 | 1153.42 |
Diluted EPS Excluding Extraordinary Items | -0.01379 | -0.00453 | -0.00625 | -0.01385 | -0.00999 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.01379 | -0.00453 | -0.00625 | -0.01385 | -0.00999 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total Current Assets | 81.001 | 16.737 | 0.308 | 9.088 | 4.651 |
Cash and Short Term Investments | 79.55 | 16.086 | 0.105 | 8.641 | 2.725 |
Cash & Equivalents | 79.55 | 16.086 | 0.105 | 8.641 | 2.725 |
Total Receivables, Net | 1.155 | 0.41 | 0.102 | 0.424 | 1.88 |
Accounts Receivable - Trade, Net | |||||
Other Current Assets, Total | |||||
Total Assets | 104.322 | 51.437 | 6.99 | 10.158 | 5.577 |
Property/Plant/Equipment, Total - Net | 14.961 | 5.726 | 6.585 | 0.973 | 0.824 |
Intangibles, Net | 0.005 | ||||
Other Long Term Assets, Total | 0.464 | 0.097 | 0.097 | 0.097 | 0.097 |
Total Current Liabilities | 8.771 | 16.374 | 15.545 | 12.45 | 11.961 |
Accounts Payable | 3.994 | 1.559 | 1.48 | 1.221 | 1.047 |
Payable/Accrued | |||||
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 1.118 | 11.185 | 9.362 | 8.275 | 7.273 |
Total Liabilities | 19.892 | 20.753 | 20.711 | 13.335 | 11.961 |
Total Long Term Debt | 11.121 | 4.379 | 5.166 | 0 | 0 |
Total Equity | 84.43 | 30.684 | -13.721 | -3.177 | -6.384 |
Common Stock | 296.524 | 156.654 | 85.011 | 68.757 | 65.133 |
Retained Earnings (Accumulated Deficit) | -212.094 | -125.97 | -105.346 | -87.731 | -71.517 |
Other Equity, Total | 0 | 6.614 | 15.797 | 0 | |
Total Liabilities & Shareholders’ Equity | 104.322 | 51.437 | 6.99 | 10.158 | 5.577 |
Total Common Shares Outstanding | 1154.06 | 998.981 | 841.467 | 811.497 | 808.995 |
Prepaid Expenses | 0.296 | 0.241 | 0.101 | 0.023 | 0.046 |
Property/Plant/Equipment, Total - Gross | 20.455 | 9.762 | 9.575 | 2.886 | 2.538 |
Accumulated Depreciation, Total | -5.494 | -4.036 | -2.99 | -1.913 | -1.714 |
Accrued Expenses | 2.43 | 2.855 | 3.993 | 2.954 | 3.641 |
Other Liabilities, Total | 0.885 | ||||
Long Term Investments | 7.896 | 28.877 | 0 | ||
Current Port. of LT Debt/Capital Leases | 1.229 | 0.775 | 0.71 | ||
Capital Lease Obligations | 11.121 | 4.379 | 5.166 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total Current Assets | 78.283 | 81.001 | 92.565 | 82.69 | 92.77 |
Cash and Short Term Investments | 71.95 | 79.55 | 91.467 | 81.257 | 88.778 |
Cash & Equivalents | 71.95 | 79.55 | 91.467 | 81.257 | 88.778 |
Total Receivables, Net | 6.333 | 1.451 | 1.098 | 1.433 | 3.992 |
Accounts Receivable - Trade, Net | 6.333 | 1.451 | 1.098 | 1.433 | 3.992 |
Total Assets | 105.758 | 104.322 | 117.112 | 96.567 | 118.308 |
Property/Plant/Equipment, Total - Net | 18.518 | 14.961 | 12.649 | 1.752 | 5.87 |
Long Term Investments | 8.493 | 7.896 | 11.434 | 11.661 | 19.571 |
Other Long Term Assets, Total | 0.464 | 0.464 | 0.464 | 0.464 | 0.097 |
Total Current Liabilities | 7.859 | 8.771 | 8.409 | 5.385 | 13.358 |
Accounts Payable | 3.721 | 3.994 | 3.124 | 1.916 | 2.211 |
Payable/Accrued | 2.869 | 2.494 | 2.972 | 2.119 | 5.231 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 1.243 | 1.229 | 1.477 | 0.31 | 0.798 |
Other Current Liabilities, Total | 0.026 | 1.054 | 0.836 | 1.04 | 5.118 |
Total Liabilities | 18.742 | 19.892 | 19.7 | 5.385 | 17.518 |
Total Long Term Debt | 10.883 | 11.121 | 11.291 | 0 | 4.16 |
Capital Lease Obligations | 10.883 | 11.121 | 11.291 | 0 | 4.16 |
Total Equity | 87.016 | 84.43 | 97.412 | 91.182 | 100.79 |
Common Stock | 307.606 | 296.524 | 295.909 | 241.537 | 204.652 |
Retained Earnings (Accumulated Deficit) | -220.59 | -212.094 | -198.497 | -163.729 | -148.104 |
Other Equity, Total | 0 | 0 | 13.374 | 44.242 | |
Total Liabilities & Shareholders’ Equity | 105.758 | 104.322 | 117.112 | 96.567 | 118.308 |
Total Common Shares Outstanding | 1167.93 | 1154.06 | 1153.42 | 1069.13 | 1067.15 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Net income/Starting Line | -90.076 | -22.021 | -22.24 | -18.735 | -20.197 |
Cash From Operating Activities | -39.839 | -15.746 | -13.113 | -13.427 | -11.823 |
Cash From Operating Activities | 1.476 | 1.067 | 1.077 | 0.197 | 0.163 |
Non-Cash Items | 57.174 | 4.89 | 5.673 | 3.143 | 7.76 |
Changes in Working Capital | -8.413 | 0.318 | 2.377 | 1.968 | 0.451 |
Cash From Investing Activities | -6.176 | -0.254 | -0.187 | -0.341 | -0.269 |
Capital Expenditures | -5.809 | -0.254 | -0.187 | -0.341 | -0.269 |
Other Investing Cash Flow Items, Total | -0.367 | 0 | 0 | ||
Cash From Financing Activities | 113.418 | 31.921 | 4.918 | 19.559 | 13.416 |
Financing Cash Flow Items | 0 | 0 | 5.435 | 16.424 | 0 |
Issuance (Retirement) of Stock, Net | 18.216 | 0.132 | 0.146 | 0.909 | 0.92 |
Issuance (Retirement) of Debt, Net | 95.202 | 31.789 | -0.663 | 2.226 | 12.496 |
Net Change in Cash | 63.464 | 15.981 | -8.536 | 5.916 | 1.324 |
Foreign Exchange Effects | -3.939 | 0.06 | -0.154 | 0.125 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -7.304 | -90.076 | -74.069 | -62.541 | -44.958 |
Cash From Operating Activities | -8.254 | -39.839 | -33.442 | -28.644 | -19.798 |
Cash From Operating Activities | 0.542 | 1.476 | 0.905 | 0.402 | 0.281 |
Non-Cash Items | -0.171 | 57.174 | 48.25 | 44.179 | 32.52 |
Changes in Working Capital | -1.321 | -8.413 | -8.528 | -10.684 | -7.641 |
Cash From Investing Activities | -4.075 | -6.176 | -3.391 | -1.237 | -0.445 |
Capital Expenditures | -4.075 | -5.809 | -3.024 | -0.87 | -0.445 |
Cash From Financing Activities | 2.816 | 113.418 | 113.478 | 95.613 | 91.829 |
Financing Cash Flow Items | 0 | 0 | 0 | 13.374 | 45.942 |
Issuance (Retirement) of Stock, Net | 3.058 | 18.216 | 17.765 | 2.879 | 2.712 |
Issuance (Retirement) of Debt, Net | -0.242 | 95.202 | 95.713 | 79.36 | 43.175 |
Foreign Exchange Effects | 1.913 | -3.939 | -1.264 | -0.561 | 1.106 |
Net Change in Cash | -7.6 | 63.464 | 75.381 | 65.171 | 72.692 |
Other Investing Cash Flow Items, Total | 0 | -0.367 | -0.367 | -0.367 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Meretzki (Shai) | Individual Investor | 32.966 | 385017966 | 5551455 | 2022-12-28 | |
Rauch (Yosef) | Individual Investor | 11.383 | 132945004 | 875000 | 2022-12-28 | |
Shapira (Gil) | Individual Investor | 0.6085 | 7106418 | 0 | 2022-12-28 | |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.1 | 1167456 | 19019 | 2023-02-28 | LOW |
Reznick (Yehuda) | Individual Investor | 0.0626 | 730797 | 0 | 2022-12-28 |
Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.
Capital.com Group500K+
Trader
92K+
Klien aktif per bulan
$53M+
Volume investasi per bulan
$30M+
Penarikan tiap bulan
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
Leverage
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Industry: | Bio Medical Devices |
פארק מת"מ 8ב'
HAIFA
3190501
IL
Income Statement
- Annual
- Quarterly
People also watch
Masih mencari broker yang bisa Anda percayai?
Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com